Vitamin D Level in Recurrent PV

Kasr El Aini Hospital

Status: Unknown

Conditions: Recurrent Pityriasis Versicolor

Treatments: Diagnostic Test: Human 25-Hydroxyvitamin D3 (HVD3) ELISA Kit (96 well)

Study type: Observational

Funder types: Other

Identifiers

NCT05067699

VitD&PV

Details and patient eligibility

About

Serum Samples will be taken from patients with recurrent Pityriasis Versicolor for the evaluation of vitamin D level.

Enrollment: 200 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• • Patients with recurrent pityriasis versicolor (active now) and not taking treatment for it.
• Patients of both genders.
• Age ≥18 years old.

Exclusion criteria

• • Patients with other cutaneous diseases.
• Patient's having dandruff (scaly scalp) even if not symptomatizing.
• Pregnant and lactating females, children, prisoners, cognitively impaired or mentally disabled subjects.
• Patients with autoimmune diseases.
• Patients with immunodeficiency diseases.
• Immunosuppressed patients e.g. HIV, diabetics, organ transplant, malignancy, patients taking immunosuppressive drugs e.g. chemotherapy, cortisone.

Trial design

200 participants in 2 patient groups

Patients

Description:

recurrent pityriasis versicolor

Treatment:

Diagnostic Test: Human 25-Hydroxyvitamin D3 (HVD3) ELISA Kit (96 well)

Controls

Description:

Healthy age and sex matched

Treatment:

Diagnostic Test: Human 25-Hydroxyvitamin D3 (HVD3) ELISA Kit (96 well)